PROGNOSTIC POTENTIAL OF F-FLURODEOXYGLUCOSE UPTAKE IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH RADICAL RADIOTHERAPY OR CONCOMITANT CHEMO-RADIOTHERAPY

被引：0
|
作者：
Lin, M. Y.
Wu, M.
Brennan, S.
Campeau, M. P.
Binns, D. [1 ]
Mac Manus, M.
Solomon, B.
Hicks, R. [1 ]
Ball, D.
机构：
[1] Peter MacCallum Canc Ctr, PET Ctr, Melbourne, Vic, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [31] Preoperative chemo-radiotherapy in stage III non-small cell lung cancer: a progress in integration of chemo-radiation
    Choi, NC
    TREATMENT OPTIMIZATION FOR LUNG CANCER: FROM CLASSICAL TO INNOVATIVE PROCEDURES, 1998, : 219 - 237
  • [32] Impact of sarcopenia in oropharyngeal cancer patients treated with radical chemo-radiotherapy
    Deantoni, C. L.
    Chiara, A.
    Mirabile, A.
    Broggi, S.
    Fiorino, C.
    Fodor, A.
    Pasetti, M.
    Tummineri, R.
    Zerbetto, F.
    Baroni, S.
    Galvan, A. Sanchez
    Gregorc, V.
    Dell'Oca, I.
    Di Muzio, N. G.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S934 - S935
  • [33] Oesophageal Dose Predicts on Treatment Toxicity in Patients Receiving Concurrent Chemo-Radiotherapy for Non-Small Cell Lung Cancer
    Keogh, C.
    Phillips, I.
    Horne, A.
    Maclennan, K.
    Tufail, A.
    Evans, T.
    Campbell, S.
    Finn, D.
    Smith, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S362 - S362
  • [34] SPARC: As a prognostic biomarker in rectal cancer patients treated with chemo-radiotherapy
    Kurtul, Neslihan
    Tasdemir, Erdem Arzu
    Unal, Dilek
    Izmirli, Mustafa
    Eroglu, Celalettin
    CANCER BIOMARKERS, 2017, 18 (04) : 459 - 466
  • [35] Managing the care of patients receiving concurrent chemo-radiotherapy for non-small cell lung cancer-lan overview
    Halkyard, E.
    Fenemore, J.
    LUNG CANCER, 2012, 75 : S34 - S35
  • [36] Concomitant chemo-radiotherapy following induction chemotherapy with paclitaxel-gemcitabine in patients with inoperable locally advanced non-small cell lung cancer (NSCLC)
    Kosmidis, P
    Fountzilas, G
    Samantas, E
    Dimopoulos, A
    Goga, H
    Skarlos, D
    Pspacostas, P
    Boukovinas, J
    Bakogiannis, C
    Nicolaides, C
    LUNG CANCER, 2005, 49 : S254 - S254
  • [37] The prognostic impact of supraclavicular lymph node in N3-IIIB stage non-small cell lung cancer patients treated with definitive concurrent chemo-radiotherapy
    Oh, Dongryul
    Ahn, Yong Chan
    Park, Hee Chul
    Lim, Do Hoon
    Noh, Jae Myoung
    Cho, Won Kyung
    Pyo, Hongryull
    ONCOTARGET, 2017, 8 (22) : 35700 - 35706
  • [38] Predictive Value of 18F-Fluorodeoxyglucose Uptake by Positron Emission Tomography for Non-Small Cell Lung Cancer Patients Treated with Radical Radiotherapy
    Ikushima, Hitoshi
    Dong, Lei
    Erasmus, Jeremy
    Allen, Pamela
    McAleer, Mary F.
    Zhuang, Yan
    Sasaki, Ryohei
    Komaki, Ritsuko
    JOURNAL OF RADIATION RESEARCH, 2010, 51 (04) : 465 - 471
  • [39] Prognostic impact of PD-L1 and TIGIT expression in non-small cell lung cancer following concurrent chemo-radiotherapy
    Mori, Masataka
    Kanayama, Masatoshi
    Kuwata, Taiji
    Manabe, Takehiko
    Nemoto, Yukiko
    Nishizawa, Natsumasa
    Oyama, Rintaro
    Matsumiya, Hiroki
    Nabe, Yusuke
    Taira, Akihiro
    Takenaka, Masaru
    Yoneda, Kazue
    Kuroda, Koji
    Tanaka, Fumihiro
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [40] Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: Current status and future development
    Guida, Cesare
    Maione, Paolo
    Rossi, Antonio
    Bareschino, Marianna
    Schettino, Clorinda
    Barzaghi, Domenico
    Elmo, Massimo
    Gridelli, Cesare
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 68 (03) : 222 - 232
12345